13 results
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
review by the FDA, Department of Justice, Department of Health and Human Services’ Office of Inspector General, state attorneys general, members
424B4
ONCR
Oncorus, Inc.
12 Feb 21
Prospectus supplement with pricing info
4:23pm
Services’ Office of Inspector General, state attorneys general, members of Congress, and the public. When the FDA or comparable foreign regulatory
DRS
ONCR
Oncorus, Inc.
28 Jan 21
Draft registration statement
12:00am
, state attorneys general, members of Congress, and the public. When the FDA or comparable foreign regulatory authorities issue regulatory approval
10-Q
8dpf2sa
12 Nov 20
Quarterly report
8:01am
424B4
e6vpo69yo63 8o8
2 Oct 20
Prospectus supplement with pricing info
12:00am
S-1
wce9fei1n va138grw
11 Sep 20
IPO registration
4:49pm
DRS/A
sd5 mnzifc
26 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
jm8b19a
29 Jul 20
Draft registration statement (amended)
12:00am
DRS/A
uxqanxh00mp6bn32ai3
20 Dec 19
Draft registration statement (amended)
12:00am
DRS
n5qa7u2kt efa8weewh
31 Oct 19
Draft registration statement
12:00am
- Prev
- 1
- Next